PET/CT Whole-body Dynamic Acquisition at FDG to Metastatic Melanoma Under Immunotherapy

RecruitingOBSERVATIONAL
Enrollment

56

Participants

Timeline

Start Date

June 26, 2020

Primary Completion Date

June 26, 2026

Study Completion Date

June 26, 2026

Conditions
Metastatic Melanoma
Interventions
DIAGNOSTIC_TEST

value of 4D body-to-whole dynamic acquisition in FDG

"differentiate pseudo-progression / progression during the first therapeutic assessment by FDG PET / CT (PET1) using data from the 4D whole-body dynamic acquisition, without having to re-evaluate closely. during a PET1 'this unconfirmed progression after 2 new treatment cures of ICI"

Trial Locations (1)

29200

RECRUITING

Hospital University ff Brest, Brest

All Listed Sponsors
lead

University Hospital, Brest

OTHER